Tipo de documento: info:eu-repo/semantics/other
DOI: 10.5061/dryad.ft0207r
Publicaciones relacionadas: Pérez-Lacasta, M. J., Martínez-Alonso, M., Garcia, M., Sala, M., Perestelo-Pérez, L., Vidal, C., Codern-Bové, N., Feijoo-Cid, M., Toledo-Chávarri, A., Cardona, À., Pons, A., Carles-Lavila, M., Rue, M., & with the InforMa Group. (2019). Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLOS ONE, 14(3), e0214057. https://doi.org/10.1371/journal.pone.0214057
Grupo de investigación: ECONOMIC CHALLENGES FOR THE NEXT GENERATION RESEARCH GROUP
Departamento: Economia
Autor: Pérez-Lacasta, M.
Fecha alta repositorio: 2022-09-19
Acción del progama de financiación: Instituto de Salud Carlos III, Award: PI14/00113
Año de publicación de la dataset: 2022
Materia: Medicina
Identificador del investigador: 0000-0001-5906-5632
DOI de la publicación relacionada: 10.1371/journal.pone.0214057
Idioma: en
Publicado por (editorial): Universitat Rovira i Virgili (URV)
Derechos de acceso: info:eu-repo/semantics/openAccess
Resumen: In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision making outcomes, in women approaching the age of invitation to mammography screening.